Pregnancy & MTCT
Pregnancy & HIV MTCT
AIDS 2014: Mothers Starting Option B+ ART in Malawi Often Lost from Care
- Details
- Category: Pregnancy & HIV MTCT
- Published on Friday, 22 August 2014 00:00
- Written by Carole Leach-Lemens
Although Malawi’s policy of offering lifelong antiretroviral therapy (ART) to women with HIV who are pregnant or breastfeeding resulted in a 7-fold increase in women receiving treatment in 15 months, implementers are concerned by high rates of loss to follow-up, researchers reported at the 20th International AIDS Conference in Melbourne.
AIDS 2014: Increased ART for Mothers Does Not Guarantee Optimal Care for Infants
- Details
- Category: Pregnancy & HIV MTCT
- Published on Thursday, 07 August 2014 00:00
- Written by Carole Leach-Lemens
The significant increase in access to antiretroviral therapy (ART) for all pregnant women living with HIV in Malawi after implementation of Option B+ contrasts with low coverage of early diagnosis and uptake of cotrimoxazole prophylaxis for HIV-exposed infants, Priscilla Idele of UNICEF reported at the 20th International AIDS Conference (AIDS 2014) last month in Melbourne.
CROI 2014: STIs Increase Risk of HIV Infection During Pregnancy
- Details
- Category: Pregnancy & HIV MTCT
- Published on Thursday, 03 April 2014 00:00
- Written by Carole Leach-Lemens
Pregnant women in Kenya have a similar risk of HIV infection during pregnancy as women in serodiscordant couples or sex workers, but women with a history of sexually transmitted infections (STIs) had nearly a 4-fold increased risk of acute HIV infection, John Kinuthia from the University of Nairobireported at the 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) last month in Boston.
Updated Perinatal ART Guidelines for Pregnant Women with HIV
- Details
- Category: Pregnancy & HIV MTCT
- Published on Thursday, 03 April 2014 00:00
- Written by AIDSinfo
The U.S. Department of Health and Human Services has updated its guidelines for use of antiretroviral drugs by pregnant women with HIV, intended both to improve the health of women and to prevent transmission of the virus to their infants during gestation or delivery.
CROI 2014: Efavirenz Matches Lopinavir/ritonavir for Perinatal HIV Treatment
- Details
- Category: Pregnancy & HIV MTCT
- Published on Tuesday, 18 March 2014 00:00
- Written by Carole Leach-Lemens
Pregnant women taking efavirenz-based antiretroviral therapy (ART) had significantly better virological outcomes at the time of delivery compared to those taking lopinavir/ ritonavir in a randomized study in rural Uganda, according to a report at the 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) in Boston this month.
More Articles...
- CROI 2014: Lopinavir or Lamivudine Equally Protective Against HIV During Breast-feeding
- Protein in Breast Milk May Help Prevent Mother-to-Child HIV Transmission
- Do HIV+ Pregnant Women on ART Need Intravenous Zidovudine During Delivery?
- ICAAC 2013: Raltegravir Appears Safe for Mothers and Babies During Pregnancy
Web Design and Development by